- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
834
Companies which are more than 50% undervalued based on analyst price target.
834 companies
Genscript Biotech
Market Cap: HK$23.7b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.92
7D
-2.3%
1Y
-13.1%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.7b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€52.75
7D
1.3%
1Y
-36.9%
Merus
Market Cap: US$3.0b
A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.
MRUS
US$40.90
7D
-7.4%
1Y
-8.1%
Scholar Rock Holding
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK
US$30.67
7D
-6.8%
1Y
129.7%
Alvotech
Market Cap: US$2.8b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$9.68
7D
17.8%
1Y
-27.6%
Protagonist Therapeutics
Market Cap: US$2.7b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$42.97
7D
-5.6%
1Y
52.2%
Xenon Pharmaceuticals
Market Cap: US$2.7b
A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.
XENE
US$35.02
7D
-8.5%
1Y
-13.6%
Metsera
Market Cap: US$2.6b
A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.
MTSR
US$23.87
7D
-6.9%
1Y
n/a
HUTCHMED (China)
Market Cap: UK£1.9b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.28
7D
-1.9%
1Y
-35.2%
LigaChem Biosciences
Market Cap: ₩3.6t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩98,900.00
7D
-8.6%
1Y
48.3%
MoonLake Immunotherapeutics
Market Cap: US$2.5b
A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.
MLTX
US$38.47
7D
-9.1%
1Y
-6.0%
Tecan Group
Market Cap: CHF 2.1b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 162.40
7D
-1.6%
1Y
-50.8%
Immunovant
Market Cap: US$2.4b
A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
IMVT
US$14.02
7D
-11.3%
1Y
-52.3%
XtalPi Holdings
Market Cap: HK$18.6b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$4.63
7D
-9.4%
1Y
n/a
Gerresheimer
Market Cap: €2.1b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€61.00
7D
0.7%
1Y
-39.2%
Organon
Market Cap: US$2.3b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$8.71
7D
-9.2%
1Y
-57.3%
Amneal Pharmaceuticals
Market Cap: US$2.3b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
AMRX
US$7.41
7D
-7.0%
1Y
11.3%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥16.9b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥10.45
7D
3.0%
1Y
-24.8%
Mirum Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$44.27
7D
1.3%
1Y
78.8%
Apellis Pharmaceuticals
Market Cap: US$2.2b
A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
APLS
US$17.30
7D
-14.9%
1Y
-58.8%
Emcure Pharmaceuticals
Market Cap: ₹190.9b
Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.
EMCURE
₹1,007.60
7D
-1.2%
1Y
n/a
Vitrolife
Market Cap: SEK 21.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 158.20
7D
2.3%
1Y
-11.3%
Apogee Therapeutics
Market Cap: US$2.2b
A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.
APGE
US$37.29
7D
-7.1%
1Y
-29.9%
NewAmsterdam Pharma
Market Cap: US$2.2b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.
NAMS
US$18.37
7D
-8.3%
1Y
-14.3%
Denali Therapeutics
Market Cap: US$2.1b
A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
DNLI
US$14.37
7D
-12.6%
1Y
-21.5%
BioCryst Pharmaceuticals
Market Cap: US$2.1b
A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
BCRX
US$9.97
7D
11.6%
1Y
87.4%
Kolon TissueGene
Market Cap: ₩2.9t
Develops cell therapies to target various orthopedic diseases and degenerative disorders.
A950160
₩35,550.00
7D
-2.6%
1Y
183.3%
Biohaven
Market Cap: US$2.1b
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.
BHVN
US$20.24
7D
-11.4%
1Y
-43.3%
Kymera Therapeutics
Market Cap: US$2.0b
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
KYMR
US$30.07
7D
-14.8%
1Y
-20.7%
Lotus Pharmaceutical
Market Cap: NT$60.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$229.00
7D
0.7%
1Y
-20.3%
Bonesupport Holding
Market Cap: SEK 19.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 288.80
7D
-6.8%
1Y
25.0%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$34.05
7D
12.3%
1Y
13.0%
Twist Bioscience
Market Cap: US$2.0b
Manufactures and sells synthetic DNA-based products.
TWST
US$30.82
7D
-21.5%
1Y
-27.3%
Bavarian Nordic
Market Cap: DKK 12.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 164.70
7D
3.2%
1Y
1.1%
Shanghai Shyndec Pharmaceutical
Market Cap: CN¥13.8b
Shanghai Shyndec Pharmaceutical Co., Ltd.
600420
CN¥10.31
7D
0.8%
1Y
-11.7%
Tarsus Pharmaceuticals
Market Cap: US$1.9b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$44.76
7D
-5.5%
1Y
21.0%